Standout Papers

Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer 2008 2026 2014 2020 2.5k
  1. Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer (2008)
    Jan B. Vermorken, Ricard Mesı́a et al. New England Journal of Medicine
  2. Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial (2009)
    Robert Pirker, Jose R. Pereira et al. The Lancet
  3. Weekly nab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Final Results of a Phase III Trial (2012)
    Mark A. Socinski, Igor Bondarenko et al. Journal of Clinical Oncology
  4. Pembrolizumab plus axitinib versus sunitinib monotherapy as first-line treatment of advanced renal cell carcinoma (KEYNOTE-426): extended follow-up from a randomised, open-label, phase 3 trial (2020)
    Thomas Powles, Elizabeth R. Plimack et al. The Lancet Oncology
  5. Multicenter Phase III Comparison of Cisplatin/S-1 With Cisplatin/Infusional Fluorouracil in Advanced Gastric or Gastroesophageal Adenocarcinoma Study: The FLAGS Trial (2010)
    Jaffer A. Ajani, W. Rodriguez et al. Journal of Clinical Oncology
  6. Atezolizumab in Combination With Carboplatin and Nab-Paclitaxel in Advanced Squamous NSCLC (IMpower131): Results From a Randomized Phase III Trial (2020)
    Robert M. Jotte, Federico Cappuzzo et al. Journal of Thoracic Oncology
  7. FAST: a randomised phase II study of zolbetuximab (IMAB362) plus EOX versus EOX alone for first-line treatment of advanced CLDN18.2-positive gastric and gastro-oesophageal adenocarcinoma (2021)
    Uğur Şahin, Ö. Türeci et al. Annals of Oncology

Immediate Impact

16 from Science/Nature 78 standout
Sub-graph 1 of 17

Citing Papers

Transferrin receptor targeting chimeras for membrane protein degradation
2024 StandoutNature
Transient loss of Polycomb components induces an epigenetic cancer fate
2024 StandoutNature
2 intermediate papers

Works of Ihor Vynnychenko being referenced

Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial
2009 Standout

Author Peers

Author Last Decade Papers Cites
Ihor Vynnychenko 4448 4232 1396 56 6.8k
Scott A. Laurie 4236 3193 1197 163 6.1k
P. Koralewski 4430 3406 2065 58 6.9k
Federica Perrone 3566 2683 2124 234 7.8k
Kelly S. Oliner 4523 2561 1241 67 6.3k
A. Harstrick 5501 2885 1901 128 8.1k
N. Azarnia 3420 2702 1358 52 6.4k
Nadia Amellal 5130 3975 2066 60 8.8k
Joseph I. Clark 3742 3056 2456 120 7.2k
Ranjan Sur 2895 2910 1287 68 6.3k
Mark Kozloff 3140 1639 1282 124 4.6k

All Works

Loading papers...

Rankless by CCL
2026